These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19403680)

  • 1. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization.
    Katpally U; Fu TM; Freed DC; Casimiro DR; Smith TJ
    J Virol; 2009 Jul; 83(14):7040-8. PubMed ID: 19403680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conserved N-terminus of human rhinovirus capsid protein VP4 contains membrane pore-forming activity and is a target for neutralizing antibodies.
    Panjwani A; Asfor AS; Tuthill TJ
    J Gen Virol; 2016 Dec; 97(12):3238-3242. PubMed ID: 27902347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of antibodies induced with a conserved rhinovirus protein generating protective anti-rhinovirus immunity.
    Sam Narean J; Glanville N; Nunn CM; Niespodziana K; Valenta R; Johnston SL; McLean GR
    Vaccine; 2019 May; 37(21):2805-2813. PubMed ID: 31003914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
    Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
    Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C.
    Iwasaki J; Smith WA; Stone SR; Thomas WR; Hales BJ
    PLoS One; 2013; 8(8):e70552. PubMed ID: 23950960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human rhinovirus 3 at 3.0 A resolution.
    Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
    Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations at the conserved N-Terminal of the human Rhinovirus capsid gene VP4, and their impact on the immune response.
    Naeem A; Alkadi HS; Manzoor MU; Yousaf I; Awadalla M; Alturaiki W; AlYami AS; Zafar A; Alosaimi B
    J Immunoassay Immunochem; 2024 May; 45(3):271-291. PubMed ID: 38551181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.
    Niespodziana K; Cabauatan CR; Pazderova P; Vacal PC; Wortmann J; Keller W; Errhalt P; Valenta R
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristoylated rhinovirus VP4 protein activates TLR2-dependent proinflammatory gene expression.
    Bentley JK; Han M; Jaipalli S; Hinde JL; Lei J; Ishikawa T; Goldsmith AM; Rajput C; Hershenson MB
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L57-L70. PubMed ID: 30908938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2.
    Hastings GZ; Speller SA; Francis MJ
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3055-9. PubMed ID: 1703215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of human rhinovirus serotype 2 (HRV2).
    Verdaguer N; Blaas D; Fita I
    J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genetic diversity and sites of recombination in human rhinovirus species C.
    McIntyre CL; McWilliam Leitch EC; Savolainen-Kopra C; Hovi T; Simmonds P
    J Virol; 2010 Oct; 84(19):10297-310. PubMed ID: 20668080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.
    Barnett PV; Rowlands DJ; Parry NR
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1295-302. PubMed ID: 8393073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection.
    Iwasaki J; Smith WA; Khoo SK; Bizzintino J; Zhang G; Cox DW; Laing IA; Le Souëf PN; Thomas WR; Hales BJ
    J Allergy Clin Immunol; 2014 Jul; 134(1):25-32. PubMed ID: 24767874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro.
    Behzadi MA; Choi A; Duehr J; Feyznezhad R; Upadhyay C; Schotsaert M; Palese P; Nachbagauer R
    Sci Rep; 2020 Jun; 10(1):9750. PubMed ID: 32546721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposals for the classification of human rhinovirus species C into genotypically assigned types.
    Simmonds P; McIntyre C; Savolainen-Kopra C; Tapparel C; Mackay IM; Hovi T
    J Gen Virol; 2010 Oct; 91(Pt 10):2409-19. PubMed ID: 20610666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral agent blocks breathing of the common cold virus.
    Lewis JK; Bothner B; Smith TJ; Siuzdak G
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6774-8. PubMed ID: 9618488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections.
    Niespodziana K; Napora K; Cabauatan C; Focke-Tejkl M; Keller W; Niederberger V; Tsolia M; Christodoulou I; Papadopoulos NG; Valenta R
    FASEB J; 2012 Mar; 26(3):1001-8. PubMed ID: 22121050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes.
    Che Z; Olson NH; Leippe D; Lee WM; Mosser AG; Rueckert RR; Baker TS; Smith TJ
    J Virol; 1998 Jun; 72(6):4610-22. PubMed ID: 9573224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.